Novel combination with maca improves sperm parameters in vitro of asthenozoospermic men.

Q3 Medicine
Israa Saleem Abdulzahra, Saad Salih Al-Dujaily, Areej Abbas Zabbon
{"title":"Novel combination with maca improves sperm parameters in vitro of asthenozoospermic men.","authors":"Israa Saleem Abdulzahra, Saad Salih Al-Dujaily, Areej Abbas Zabbon","doi":"10.3233/HAB-240032","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Infertility is an inability to conceive after a reasonable period of time (12 months) without the use of contraception or due to a person's incapacity to procreate, whether independently or with a spouse. Problems with the production and maturation of sperm are the most common causes of male infertility additionally; the motility is the major functional character that determines the fertilizing ability of spermatozoa. Therefore the goal of this study is to get better certain sperm function parameters in vitro of asthenozoospermic patient.</p><p><strong>Objective: </strong>The World Health Organization (WHO) and many studies considered the infertility as a disease and so many couples complaining from unsuccessful assisted reproductive technologies (ART) procedures to overcome their problem. The goal of this study is to improve certain sperm function feature in vitro of asthenozoospermic semen patients by using combination of motility inducing namely; Maca, L-carnitine and Pentoxifylline that enhance the medium to improve certain sperm characters that might be utilized for ART centers.</p><p><strong>Methodology: </strong>Semen aliquots were collected from ninety patients with asthenozoospermia who participated in present study, the volume of semen samples with normal ejaculate when was ranged between 1.4-6ml and can be measured by using a measure pipette or conical graduated tube; Inclusion criteria was Asthenozoospermia, oligozoospermia and teratozoospermia men, Infertile idiopathic men also, fertile normozoospermic men. While Exclusion criteria was Azoospermic men, Alcoholic, Patients under treatment with antibiotics and men with Varicocele.The samples split into two equal groups at random. Using Ham's F12 medium, one portion served as the control group, and the other was the treatment group, which was mixing by combining the following ingredients, Maca powder extracts (Lepidium meyenii) (M) 1 mg/ml, 0.5 mg/ml of L-Carnitine (LC), and 10 mg/ml of Pentoxifylline (PTX). The data were analyzed using Statistical Package for Social Sciences (SPSS) version 23.0. The descriptive statistics including frequency, range, mean and standard error, Data from treated and control groups were expressed as mean ± SEM and to compare value between experimental and control groups using Students t-test. Layering approach is used to investigate sperm parameters before and after in vitro activation.</p><p><strong>Results: </strong>The information showed a very large (p< 0.001) increase in active sperm motility grade A, percentage of progressive motility with significant increase in morphologically normal sperm (MNS) with decreased in DNA fragmentation index after activation by layering technique with novel combination medium compared to Hams F12 medium and before activation.</p><p><strong>Conclusion: </strong>The present work stated that novel combination medium (LC, maca and PXT) have potential effects to improve sperm characters in male infertility factors and suggested to be used for sperm preparation and activation in ART programs.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"221-227"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/HAB-240032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Infertility is an inability to conceive after a reasonable period of time (12 months) without the use of contraception or due to a person's incapacity to procreate, whether independently or with a spouse. Problems with the production and maturation of sperm are the most common causes of male infertility additionally; the motility is the major functional character that determines the fertilizing ability of spermatozoa. Therefore the goal of this study is to get better certain sperm function parameters in vitro of asthenozoospermic patient.

Objective: The World Health Organization (WHO) and many studies considered the infertility as a disease and so many couples complaining from unsuccessful assisted reproductive technologies (ART) procedures to overcome their problem. The goal of this study is to improve certain sperm function feature in vitro of asthenozoospermic semen patients by using combination of motility inducing namely; Maca, L-carnitine and Pentoxifylline that enhance the medium to improve certain sperm characters that might be utilized for ART centers.

Methodology: Semen aliquots were collected from ninety patients with asthenozoospermia who participated in present study, the volume of semen samples with normal ejaculate when was ranged between 1.4-6ml and can be measured by using a measure pipette or conical graduated tube; Inclusion criteria was Asthenozoospermia, oligozoospermia and teratozoospermia men, Infertile idiopathic men also, fertile normozoospermic men. While Exclusion criteria was Azoospermic men, Alcoholic, Patients under treatment with antibiotics and men with Varicocele.The samples split into two equal groups at random. Using Ham's F12 medium, one portion served as the control group, and the other was the treatment group, which was mixing by combining the following ingredients, Maca powder extracts (Lepidium meyenii) (M) 1 mg/ml, 0.5 mg/ml of L-Carnitine (LC), and 10 mg/ml of Pentoxifylline (PTX). The data were analyzed using Statistical Package for Social Sciences (SPSS) version 23.0. The descriptive statistics including frequency, range, mean and standard error, Data from treated and control groups were expressed as mean ± SEM and to compare value between experimental and control groups using Students t-test. Layering approach is used to investigate sperm parameters before and after in vitro activation.

Results: The information showed a very large (p< 0.001) increase in active sperm motility grade A, percentage of progressive motility with significant increase in morphologically normal sperm (MNS) with decreased in DNA fragmentation index after activation by layering technique with novel combination medium compared to Hams F12 medium and before activation.

Conclusion: The present work stated that novel combination medium (LC, maca and PXT) have potential effects to improve sperm characters in male infertility factors and suggested to be used for sperm preparation and activation in ART programs.

与玛卡的新组合可改善无精子症男性的体外精子参数。
背景:不孕症是指在没有采取避孕措施的情况下,或由于个人没有生育能力,无论是独立生育还是与配偶共同生育,在一段合理的时间内(12 个月)无法受孕。此外,精子的生成和成熟问题是导致男性不育的最常见原因;精子活力是决定精子受精能力的主要功能特征。因此,本研究的目的是更好地了解无精症患者体外的某些精子功能参数:世界卫生组织(WHO)和许多研究都认为不孕不育是一种疾病,因此许多夫妇都抱怨辅助生殖技术(ART)治疗不成功。本研究的目的是通过使用玛卡、左旋肉碱和五氧嘧啶等运动诱导剂,改善无精子症患者精液的某些精子功能特征:从参与本研究的 90 名无精子症患者中收集精液等分,正常射精时的精液样本量在 1.4-6 毫升之间,可使用计量吸管或锥形刻度管测量;纳入标准为无精子症、少精子症和畸形精子症男性、特发性不育男性以及可育的正常无精子症男性。排除标准为无精子症男性、酗酒者、接受抗生素治疗的患者和患有精索静脉曲张的男性。样本随机分成两组。使用 Ham's F12 培养基,其中一部分作为对照组,另一部分作为治疗组,治疗组由以下成分混合而成:玛咖粉提取物(Lepidium meyenii)(M)1 毫克/毫升、左旋肉碱(LC)0.5 毫克/毫升和五氧化锡(PTX)10 毫克/毫升。数据采用社会科学统计软件包(SPSS)23.0 版进行分析。描述性统计包括频率、范围、平均值和标准误差,治疗组和对照组的数据以平均值 ± SEM 表示,实验组和对照组的数据比较采用学生 t 检验。采用分层法研究体外激活前后的精子参数:结果:信息显示,与哈姆斯 F12 培养基和激活前相比,新型组合培养基通过分层技术激活后,A 级活跃精子活力、渐进式活力百分比大幅增加(p< 0.001),形态正常精子(MNS)显著增加,DNA 碎片指数下降:本研究结果表明,新型组合培养基(LC、玛咖和PXT)具有改善男性不育因素中精子特征的潜在作用,建议在ART项目中用于精子制备和激活。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Antibodies
Human Antibodies Medicine-Immunology and Allergy
CiteScore
3.50
自引率
0.00%
发文量
27
期刊介绍: Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信